Mydecine Innovations logo white

Mydecine Innovations Group

CSE: MYCO | OTC: MYCOF | FWB: 0NF

Mydecine Innovations Group is a publicly traded life sciences syndicate. The Company’s portfolio includes natural health products, research and development, and digital health solutions.

NewLeaf Brands changed its name to Mydecine in June 2020. NewLeaf was a CBD lifestyle company, that then expanded into the shroom space. In May 2020, the company announced that  Mydecine Group, is building-out a specialist mycology lab in Denver, Colorado.

MYDECINE INNOVATIONS GROUP INC
$0.2136
-1.75%
$0.0000

Our team aims to be at the forefront of the efficient development of psychedelic medicine derived from fungi and therapeutic solutions. In such a short time, we have been able to accomplish advancement for the potential use of psilocybin in the treatment of PTSD with the clinical trials that we just initiated in the Netherlands.

Josh Bartch, CEO (Aug 2020)

Join our Newsletter

Get the latest Company updates delivered to straight to your inbox.